GARAMYCIN Side Effects

5442990-4 | Eye Discharge, Eye Pain, Eye Swelling
on Aug 29, 2007 Male patient from BRAZIL , child 2 years of age, weighting 35.27 lb, was treated with Garamycin (View Usage). Patient experienced the following unwanted or unexpected effects: eye discharge, eye pain, eye swelling. Garamycin dosage: Unk, Q12h. During the same period patient was treated with TOBREX (Unk, Bid) (View Tobrex Review and Tobrex Label ), CATAFLAM (75 Mg, Once/single) (View Cataflam Review and Cataflam Label ).

4678304-7 | Astigmatism, Corneal Disorder, Corneal Opacity, Eye Pain, Lacrimation Increased, Photophobia
Patient was taking Garamycin (View Usage). Patient had the following side effects: astigmatism, corneal disorder, corneal opacity, eye pain, lacrimation increased, photophobia on May 20, 2005 from Additional patient health information: Male patient , 30 years of age, was diagnosed with keratitis and. Garamycin dosage: Q1h Ophthalmic. During the same period patient was treated with CHLORAMPHENICOL (Q1h Ophthalmic) (View Chloramphenicol Review and Chloramphenicol Label ).

4628580-1 | Application Site Photosensitivity Reaction, Application Site Reaction, Eye Irritation, Ocular Hyperaemia
Adverse event was reported on Mar 28, 2005 by a Female patient taking Garamycin (View Usage) (Dosage: 2 Gtt Ou Qid Ophthalmic) was diagnosed with conjunctivitis and. Location: , child 8 years of age, After Garamycin was administered, patient had the following side effects: application site photosensitivity reaction, application site reaction, eye irritation, ocular hyperaemia. During the same period patient was treated with FLOVENT (View Flovent Review and Flovent Label ).

4621194-9 | Eye Irritation, Ocular Hyperaemia, Photophobia
on Mar 18, 2005 Female patient from , child 8 years of age, was diagnosed with conjunctivitis and was treated with Garamycin (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, ocular hyperaemia, photophobia. Garamycin dosage: 2 Gtt Ou Qid Ophthalmic. During the same period patient was treated with FLOVENT (View Flovent Review and Flovent Label ).


4563666-1 | Difficulty In Walking
on Jan 12, 2005 Female patient from , 77 years of age, was treated with Garamycin (View Usage). Patient had the following side effects: difficulty in walking. Garamycin dosage: 150 Mg Tid Intramuscular. During the same period patient was treated with LOZIDE TABLETS (View Lozide Tablets Review and Lozide Tablets Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

4563665-X | Altered Visual Depth Perception, Cerebral Atrophy, Coordination Abnormal, Deafness Neurosensory, Decreased Activity, Diabetes Mellitus Inadequate Control, Diabetic Retinopathy, Difficulty In Walking, Disease Progression
Patient was taking Garamycin (View Usage). After Garamycin was administered, patient had the following side effects: altered visual depth perception, cerebral atrophy, coordination abnormal, deafness neurosensory, decreased activity, diabetes mellitus inadequate control, diabetic retinopathy, difficulty in walking, disease progression on Jan 12, 2005 from Additional patient health information: Male patient , 61 years of age, weighting 210.0 lb, was diagnosed with diabetic foot and. Garamycin dosage: 500-480 Mg*qd Intravenous. During the same period patient was treated with TIMOPTIC OPHTHALMIC SOLUTION (View Timoptic Ophthalmic Solution Review and Timoptic Ophthalmic Solution Label ), INSULIN INJECTABLE (View Insulin Injectable Review and Insulin Injectable Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROPINE OPHTHALMIC SOLUTION (View Propine Ophthalmic Solution Review and Propine Ophthalmic Solution Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized and became disabled.

4560748-5 | Pulmonary Oedema, Pulse Pressure Decreased, Vertigo
Adverse event was reported on Jan 12, 2005 by a Female patient taking Garamycin (View Usage) (Dosage: 150 Mg Tid Intramuscular) . Location: , 77 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary oedema, pulse pressure decreased, vertigo. During the same period patient was treated with LOZIDE TABLES (View Lozide Tables Review and Lozide Tables Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

4560740-0 | Balance Disorder, Blood Creatinine Increased, Muscle Spasms, Ototoxicity, Pulmonary Oedema, Vertigo
on Jan 12, 2005 Female patient from , 76 years of age, was treated with Garamycin (View Usage). Patient had the following side effects: balance disorder, blood creatinine increased, muscle spasms, ototoxicity, pulmonary oedema, vertigo. Garamycin dosage: 150 Mg Tid Intramuscular. During the same period patient was treated with . (View . Review and . Label ), ACEBUTOLOL HCL (View Acebutolol Hcl Review and Acebutolol Hcl Label ), ADALAT (View Adalat Review and Adalat Label ), LOZIDE TABLETS (View Lozide Tablets Review and Lozide Tablets Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

4560736-9 | Balance Disorder, Blood Creatinine Increased, Blood Urea Increased, Haemodialysis, Hearing Impaired, Hyperkalaemia
on Jan 12, 2005 Male patient from , 63 years of age, was treated with Garamycin (View Usage). After Garamycin was administered, patient had the following side effects: balance disorder, blood creatinine increased, blood urea increased, haemodialysis, hearing impaired, hyperkalaemia. Garamycin dosage: 480 Mg Qd Intravenous. During the same period patient was treated with FUROSEMIDE (160 Mg Qd Oral) (View Furosemide Review and Furosemide Label ), ENALAPRIL MALEATE (10 Mg Qd Oral) (View Enalapril Maleate Review and Enalapril Maleate Label ), CLOXACILLIN (4 Grams Qd Intravenous) (View Cloxacillin Review and Cloxacillin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

4560720-5 | Pyrexia, Respiratory Distress, Tremor
Patient was taking Garamycin (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, respiratory distress, tremor on Jan 12, 2005 from Additional patient health information: Female patient , child 2 years of age, . Garamycin dosage: 27 Mg Intravenous.